Keywordsceliac; gluten; protease; IL-15; oral supplement; gluten-free; rhesus macaque; glutenase; gluten-sensitive enteropathy; celiac disease; gastrointestinal diseases; symptoms; gluten-free diet; gluten free diet; celiac disease; mucosal recovery; gluten contamination; gluten; celiac disease; NCGS; wheat allergy; gluten intolerance; gliadin; glutenin; hordein; secalin; avenin; coeliac disease; gluten free diet; probiotic; Bifidobacterium breve; intestinal microbiota; qPCR; next generation sequencing; celiac; gluten; gut; microbiome; microbiota; dysbiosis; rhesus; macaque; metagenomics; 16S rRNA; miRNA; chronic inflammation; gluten; non-celiac gluten sensitivity; non-celiac wheat sensitivity; celiac disease; irritable bowel syndrome; FODMAPs; gluten-free; cereal based foodstuff; gluten content evolution; ELISA; European regulation; wheat allergy; specific immunoglobulin E; children; gluten-related disorders; gluten; gluten contamination; food safety; celiac disease; gluten related disorders; celiac disease; gluten-free diet; gluten immunogenic peptides; feces; urine; gluten; non-celiac gluten sensitivity; non-celiac wheat sensitivity; wheat allergy; celiac disease; prevalence; celiac disease; bone disorders; osteoporosis; histopathology; intestinal mucosa healing; non‐celiac wheat sensitivity; nickel allergy; cutaneous symptoms; irritable bowel syndrome; celiac disease; gluten-free products; naturally gluten-free; R5 ELISA; oats; buckwheat; lentils; computerised image‐analysis; celiac mucosa; Marsh classification; ROC‐curve analysis; IEL; lymphocyte immuno‐subtypes; mesenteric immune system; invalid Marsh III a,b,c sub‐classification; low-FODMAP diet; irritable bowel syndrome; non-celiac gluten sensitivity; fermentable sugars; polyols; nutritional risk; gluten-free diet; coeliac disease; non-coeliac gluten sensitivity
